Bacteriophages and Lysins in Biofilm Control
To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the r...
Gespeichert in:
Veröffentlicht in: | Virologica Sinica 2020-04, Vol.35 (2), p.125-133 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 133 |
---|---|
container_issue | 2 |
container_start_page | 125 |
container_title | Virologica Sinica |
container_volume | 35 |
creator | Łusiak-Szelachowska, Marzanna Weber-Dąbrowska, Beata Górski, Andrzej |
description | To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the role of bacteriophages in the prevention and elimination of biofilm-related infections has been emphasized.
In vitro
,
ex vivo
and
in vivo
biofilm treatment models with single bacteriophages or phage cocktails have been compared. A combined use of bacteriophages with antibiotics
in vitro
or
in vivo
confirms earlier reports of the synergistic effect of these agents in improving biofilm removal. Furthermore, studies on the application of phage-derived lysins
in vitro, ex vivo
or
in vivo
against biofilm-related infections are encouraging. The strategy of combined use of phage and antibiotics seems to be different from using lysins and antibiotics. These findings suggest that phages and lysins alone or in combination with antibiotics may be an efficient weapon against biofilm formation
in vivo
and
ex vivo,
which could be useful in formulating novel strategies to combat bacterial infections. Those findings proved to be relevant in the prevention and destruction of biofilms occurring during urinary tract infections, orthopedic implant-related infections, periodontal and peri-implant infections. In conclusion, it appears that most efficient strategy of eliminating biofilms involves phages or lysins in combination with antibiotics, but the optimal scheme of their administration requires further studies. |
doi_str_mv | 10.1007/s12250-019-00192-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7198674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2370505523</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-cba94ef0b13a30a020ccf25f5e1891c769f6f3572c1dc41234974022ff071ec73</originalsourceid><addsrcrecordid>eNp9kUFPGzEQha0KRCDlD_SAVuLSA0vHY3u9vlSCiLZIkXoBqTfLcezE0Wad2kkl_j0OSdPCgYttaT6_eTOPkE8UrimA_JIpooAaqKqhHFizD-SUKiXqFuHXUXk3ktcgGzUgZzkvABpsGTshA4YURcPZKbm6NXbtUoiruZm5XJl-Wo2fcuhzFfrqNkQfumU1iv06xe4jOfamy-58fw_J47e7h9GPevzz-_3oZlxbLvm6thOjuPMwocwwMIBgrUfhhaOtorb48Y1nQqKlU8spMq4kB0TvQVJnJRuSrzvd1WaydFPrSnfT6VUKS5OedDRBv670Ya5n8Y-WVLVl5iLweS-Q4u-Ny2u9DNm6rjO9i5uskUkQIASygl6-QRdxk_oyXqFUi8gbtXWEO8qmmHNy_mCGgt6GoXdh6JKDfglDb6Uv_h_j8OXv9gvAdkAupX7m0r_e78g-AzRQk50</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2398224697</pqid></control><display><type>article</type><title>Bacteriophages and Lysins in Biofilm Control</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><creator>Łusiak-Szelachowska, Marzanna ; Weber-Dąbrowska, Beata ; Górski, Andrzej</creator><creatorcontrib>Łusiak-Szelachowska, Marzanna ; Weber-Dąbrowska, Beata ; Górski, Andrzej</creatorcontrib><description>To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the role of bacteriophages in the prevention and elimination of biofilm-related infections has been emphasized.
In vitro
,
ex vivo
and
in vivo
biofilm treatment models with single bacteriophages or phage cocktails have been compared. A combined use of bacteriophages with antibiotics
in vitro
or
in vivo
confirms earlier reports of the synergistic effect of these agents in improving biofilm removal. Furthermore, studies on the application of phage-derived lysins
in vitro, ex vivo
or
in vivo
against biofilm-related infections are encouraging. The strategy of combined use of phage and antibiotics seems to be different from using lysins and antibiotics. These findings suggest that phages and lysins alone or in combination with antibiotics may be an efficient weapon against biofilm formation
in vivo
and
ex vivo,
which could be useful in formulating novel strategies to combat bacterial infections. Those findings proved to be relevant in the prevention and destruction of biofilms occurring during urinary tract infections, orthopedic implant-related infections, periodontal and peri-implant infections. In conclusion, it appears that most efficient strategy of eliminating biofilms involves phages or lysins in combination with antibiotics, but the optimal scheme of their administration requires further studies.</description><identifier>ISSN: 1674-0769</identifier><identifier>EISSN: 1995-820X</identifier><identifier>DOI: 10.1007/s12250-019-00192-3</identifier><identifier>PMID: 32125643</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Bacterial infections ; Bacteriophages - chemistry ; Biochemistry ; Biofilms ; Biofilms - drug effects ; Biomedical and Life Sciences ; Biomedicine ; Communicable Diseases - therapy ; Drug Therapy, Combination ; Humans ; Infections ; Lysins ; Medical Microbiology ; Microbial Genetics and Genomics ; Microbiology ; Oncology ; Phage Therapy ; Phages ; Review ; Urinary tract ; Viral Proteins - therapeutic use ; Virology</subject><ispartof>Virologica Sinica, 2020-04, Vol.35 (2), p.125-133</ispartof><rights>Wuhan Institute of Virology, CAS 2020</rights><rights>Wuhan Institute of Virology, CAS 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-cba94ef0b13a30a020ccf25f5e1891c769f6f3572c1dc41234974022ff071ec73</citedby><cites>FETCH-LOGICAL-c474t-cba94ef0b13a30a020ccf25f5e1891c769f6f3572c1dc41234974022ff071ec73</cites><orcidid>0000-0001-5349-8349 ; 0000-0001-8535-258X ; 0000-0002-0863-6041</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198674/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198674/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27926,27927,41490,42559,51321,53793,53795</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32125643$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Łusiak-Szelachowska, Marzanna</creatorcontrib><creatorcontrib>Weber-Dąbrowska, Beata</creatorcontrib><creatorcontrib>Górski, Andrzej</creatorcontrib><title>Bacteriophages and Lysins in Biofilm Control</title><title>Virologica Sinica</title><addtitle>Virol. Sin</addtitle><addtitle>Virol Sin</addtitle><description>To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the role of bacteriophages in the prevention and elimination of biofilm-related infections has been emphasized.
In vitro
,
ex vivo
and
in vivo
biofilm treatment models with single bacteriophages or phage cocktails have been compared. A combined use of bacteriophages with antibiotics
in vitro
or
in vivo
confirms earlier reports of the synergistic effect of these agents in improving biofilm removal. Furthermore, studies on the application of phage-derived lysins
in vitro, ex vivo
or
in vivo
against biofilm-related infections are encouraging. The strategy of combined use of phage and antibiotics seems to be different from using lysins and antibiotics. These findings suggest that phages and lysins alone or in combination with antibiotics may be an efficient weapon against biofilm formation
in vivo
and
ex vivo,
which could be useful in formulating novel strategies to combat bacterial infections. Those findings proved to be relevant in the prevention and destruction of biofilms occurring during urinary tract infections, orthopedic implant-related infections, periodontal and peri-implant infections. In conclusion, it appears that most efficient strategy of eliminating biofilms involves phages or lysins in combination with antibiotics, but the optimal scheme of their administration requires further studies.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Bacterial infections</subject><subject>Bacteriophages - chemistry</subject><subject>Biochemistry</subject><subject>Biofilms</subject><subject>Biofilms - drug effects</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Communicable Diseases - therapy</subject><subject>Drug Therapy, Combination</subject><subject>Humans</subject><subject>Infections</subject><subject>Lysins</subject><subject>Medical Microbiology</subject><subject>Microbial Genetics and Genomics</subject><subject>Microbiology</subject><subject>Oncology</subject><subject>Phage Therapy</subject><subject>Phages</subject><subject>Review</subject><subject>Urinary tract</subject><subject>Viral Proteins - therapeutic use</subject><subject>Virology</subject><issn>1674-0769</issn><issn>1995-820X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFPGzEQha0KRCDlD_SAVuLSA0vHY3u9vlSCiLZIkXoBqTfLcezE0Wad2kkl_j0OSdPCgYttaT6_eTOPkE8UrimA_JIpooAaqKqhHFizD-SUKiXqFuHXUXk3ktcgGzUgZzkvABpsGTshA4YURcPZKbm6NXbtUoiruZm5XJl-Wo2fcuhzFfrqNkQfumU1iv06xe4jOfamy-58fw_J47e7h9GPevzz-_3oZlxbLvm6thOjuPMwocwwMIBgrUfhhaOtorb48Y1nQqKlU8spMq4kB0TvQVJnJRuSrzvd1WaydFPrSnfT6VUKS5OedDRBv670Ya5n8Y-WVLVl5iLweS-Q4u-Ny2u9DNm6rjO9i5uskUkQIASygl6-QRdxk_oyXqFUi8gbtXWEO8qmmHNy_mCGgt6GoXdh6JKDfglDb6Uv_h_j8OXv9gvAdkAupX7m0r_e78g-AzRQk50</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Łusiak-Szelachowska, Marzanna</creator><creator>Weber-Dąbrowska, Beata</creator><creator>Górski, Andrzej</creator><general>Springer Singapore</general><general>KeAi Publishing Communications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5349-8349</orcidid><orcidid>https://orcid.org/0000-0001-8535-258X</orcidid><orcidid>https://orcid.org/0000-0002-0863-6041</orcidid></search><sort><creationdate>20200401</creationdate><title>Bacteriophages and Lysins in Biofilm Control</title><author>Łusiak-Szelachowska, Marzanna ; Weber-Dąbrowska, Beata ; Górski, Andrzej</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-cba94ef0b13a30a020ccf25f5e1891c769f6f3572c1dc41234974022ff071ec73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Bacterial infections</topic><topic>Bacteriophages - chemistry</topic><topic>Biochemistry</topic><topic>Biofilms</topic><topic>Biofilms - drug effects</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Communicable Diseases - therapy</topic><topic>Drug Therapy, Combination</topic><topic>Humans</topic><topic>Infections</topic><topic>Lysins</topic><topic>Medical Microbiology</topic><topic>Microbial Genetics and Genomics</topic><topic>Microbiology</topic><topic>Oncology</topic><topic>Phage Therapy</topic><topic>Phages</topic><topic>Review</topic><topic>Urinary tract</topic><topic>Viral Proteins - therapeutic use</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Łusiak-Szelachowska, Marzanna</creatorcontrib><creatorcontrib>Weber-Dąbrowska, Beata</creatorcontrib><creatorcontrib>Górski, Andrzej</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Virologica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Łusiak-Szelachowska, Marzanna</au><au>Weber-Dąbrowska, Beata</au><au>Górski, Andrzej</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bacteriophages and Lysins in Biofilm Control</atitle><jtitle>Virologica Sinica</jtitle><stitle>Virol. Sin</stitle><addtitle>Virol Sin</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>35</volume><issue>2</issue><spage>125</spage><epage>133</epage><pages>125-133</pages><issn>1674-0769</issn><eissn>1995-820X</eissn><abstract>To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the role of bacteriophages in the prevention and elimination of biofilm-related infections has been emphasized.
In vitro
,
ex vivo
and
in vivo
biofilm treatment models with single bacteriophages or phage cocktails have been compared. A combined use of bacteriophages with antibiotics
in vitro
or
in vivo
confirms earlier reports of the synergistic effect of these agents in improving biofilm removal. Furthermore, studies on the application of phage-derived lysins
in vitro, ex vivo
or
in vivo
against biofilm-related infections are encouraging. The strategy of combined use of phage and antibiotics seems to be different from using lysins and antibiotics. These findings suggest that phages and lysins alone or in combination with antibiotics may be an efficient weapon against biofilm formation
in vivo
and
ex vivo,
which could be useful in formulating novel strategies to combat bacterial infections. Those findings proved to be relevant in the prevention and destruction of biofilms occurring during urinary tract infections, orthopedic implant-related infections, periodontal and peri-implant infections. In conclusion, it appears that most efficient strategy of eliminating biofilms involves phages or lysins in combination with antibiotics, but the optimal scheme of their administration requires further studies.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>32125643</pmid><doi>10.1007/s12250-019-00192-3</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-5349-8349</orcidid><orcidid>https://orcid.org/0000-0001-8535-258X</orcidid><orcidid>https://orcid.org/0000-0002-0863-6041</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1674-0769 |
ispartof | Virologica Sinica, 2020-04, Vol.35 (2), p.125-133 |
issn | 1674-0769 1995-820X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7198674 |
source | MEDLINE; PubMed Central; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings |
subjects | Anti-Bacterial Agents - therapeutic use Antibiotics Bacterial infections Bacteriophages - chemistry Biochemistry Biofilms Biofilms - drug effects Biomedical and Life Sciences Biomedicine Communicable Diseases - therapy Drug Therapy, Combination Humans Infections Lysins Medical Microbiology Microbial Genetics and Genomics Microbiology Oncology Phage Therapy Phages Review Urinary tract Viral Proteins - therapeutic use Virology |
title | Bacteriophages and Lysins in Biofilm Control |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T09%3A38%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bacteriophages%20and%20Lysins%20in%20Biofilm%20Control&rft.jtitle=Virologica%20Sinica&rft.au=%C5%81usiak-Szelachowska,%20Marzanna&rft.date=2020-04-01&rft.volume=35&rft.issue=2&rft.spage=125&rft.epage=133&rft.pages=125-133&rft.issn=1674-0769&rft.eissn=1995-820X&rft_id=info:doi/10.1007/s12250-019-00192-3&rft_dat=%3Cproquest_pubme%3E2370505523%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2398224697&rft_id=info:pmid/32125643&rfr_iscdi=true |